Certified by Founder Lodge
Catalys Pacific
Japan - Minato-ku, Tokyo
INVESTOR
1 Disclosed Funding Rounds $150,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Leveraging its networks in academia, biotech, venture capital and the pharmaceutical industry, Catalys Pacific has assembled a group of Strategic and Preferred Partners with whom to create as
| Company | Date | Round | Raised |
|---|---|---|---|
 Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
 Pathalys Pharma |
February, 07 ,2023 | Unknown | $150,000,000 |
 Arialys Therapeutics, Inc. |
September, 13 ,2023 | Seed | $58,000,000 |
| Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
